Clinical and molecular characterization of five new individuals with WAC‐related intellectual disability: Evidence of pathogenicity for a novel splicing variant. Issue 5 (12th January 2022)

• Record Type: Journal Article
• Authors: Morales, Jose Andres; Valenzuela, Irene; Cuscó, Ivon; Cogné, Benjamin; Isidor, Bertrand; Matalon, Dena R.; Gomez‐Ospina, Natalia
• Is Part Of: American journal of medical genetics. Volume 188:Issue 5(2022)
• Page Start: 1396
• Page End: 1406
• Publication Date: 2022-01-12
• Subjects: autism -- DeSanto‐Shinawi syndrome -- developmental delay -- dysmorphism -- intellectual disability -- WAC; Medical genetics -- Periodicals; 616.14205
• DOI: 10.1002/ajmg.a.62648
• Languages: English
• ISSNs: 1552-4825

Abstract

Abstract: WAC ‐related intellectual disability (ID) is a rare genetic condition characterized by a spectrum of neurodevelopmental disorders of varying severity, including global developmental delay (GDD), ID, and autism spectrum disorder. Here, we describe five affected individuals, age range 9–20 years, and provide proof of pathogenicity of a novel splicing variant. All individuals presented with GDD, some degree of ID, and variable dysmorphism. Except for feeding difficulties, all patients were healthy without major congenital malformations or medical comorbidities. All individuals were heterozygous for de novo, previously unreported, loss of function variants in WAC . Three unrelated patients from different ethnic backgrounds shared the intronic variant c.381+4_381+7delAGTA, which was predicted to alter splicing and was initially classified as a variant of uncertain significance. Reverse transcription‐polymerase chain reaction analysis from one patient's cells confirmed aberrant splicing of the WAC transcript resulting in premature termination and a truncated protein p.(Gly92Alafs*2). These functional studies and the identification of several nonrelated individuals provide sufficient evidence to classify this variant as pathogenic. The clinical description of these five individuals and the three novel variants expand the genotypic and phenotypic spectrum of this ultrarare disease.